Browsing Tag
Cancer treatment
82 posts
Can J&J’s five-minute NSCLC injection disrupt the EGFR frontline market long ruled by osimertinib?
Johnson & Johnson’s five-minute NSCLC injection RYBREVANT FASPRO wins FDA approval. Learn how this subcutaneous delivery could reshape EGFR frontline therapy.
How SOPHiA GENETICS’ AI Digital Twins could transform oncology treatment forever
Find out how SOPHiA GENETICS’ new AI-powered Digital Twins could revolutionize cancer care and reshape global oncology economics.
Can medicinal plants play a larger role in cancer treatment as awareness grows in India?
Can medicinal plants play a bigger role in cancer care? Explore their contribution to modern drugs, preventive nutrition, and India’s free online Cancer Information Service.
Genentech’s Lunsumio and Polivy combination triples remission in relapsed large B-cell lymphoma
Genentech's chemo-free Lunsumio and Polivy combo tripled remission time in relapsed B-cell lymphoma, signaling a shift toward outpatient oncology treatment.
Humana expands value-based care with new cancer and kidney disease initiatives
Humana Inc., a leading health and well-being company, has reinforced its commitment to value-based care by introducing two…
Gloriosa Superba: Chemical constituents, medicinal uses, and pharmaceutical importance
Gloriosa superba, commonly referred to as the glory lily, is a highly valued medicinal plant recognized for its…
Bristol Myers Squibb’s Opdualag fails to meet primary endpoint in Phase 3 trial
Bristol Myers Squibb has announced that its Phase 3 RELATIVITY-098 clinical trial, designed to evaluate Opdualag (nivolumab and…
City of Hope researchers unveil thymus regeneration therapy for immune system repair
Scientists at City of Hope, one of the most renowned cancer research and treatment institutions in the United…
Dr Reddy’s launches toripalimab in India as first immuno-oncology drug for nasopharyngeal carcinoma
Dr. Reddy’s Laboratories Ltd. announced a significant milestone in its oncology portfolio with the launch of Toripalimab in…
BeiGene stock surges on EU approval for TEVIMBRA in advanced cancer treatment
BeiGene, a global oncology company, announced that the European Commission has granted regulatory approval for TEVIMBRA (tislelizumab), its…